Feature | January 26, 2015

Majority of Primary Care Physicians Believe that Medical Imaging Improves Patient Care

Study published in the Journal of the American College of Radiology

clinical trial/study, imaging, CT imaging

January 26, 2015 — According to a study published online in the Journal of the American College of Radiology (JACR), large majorities of primary care physicians believe that advanced medical imaging, such as computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) provides considerable value to patient care.

A national survey of 500 primary care physicians was conducted using an online self-administered questionnaire. Study results showed that primary care physicians overwhelmingly indicated that advanced imaging:

·       Increases their diagnostic confidence

·       Provides data not otherwise available

·       Permits better clinical decisions

·       Increases confidence in treatment choices

·       Shortens time to definitive diagnosis

Primary care physicians whose careers predated the widespread availability of advanced medical imaging tended to associate it with even higher value.

"As this study demonstrates, the overall ability of advanced medical imaging to facilitate rapid and accurate diagnoses has contributed to PCPs' perception of its value," said Richard Duszak, M.D., co-author of the study and chief medical officer and senior research fellow of the Harvey L. Neiman Health Policy Institute. "Advanced medical imaging facilitates patient triage, and for sicker patients, decreases the frequency of exploratory surgery and shortens hospital lengths of stay."

 

For more information: www.jacr.org

 


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now